Patents by Inventor Matthew Hilborn

Matthew Hilborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11972469
    Abstract: A system for categorizing, visualizing, and recommending Cannabis products based on objective data of the chemical composition of products is described. This system allows Cannabis products to be visualized and compared based on their chemical composition, even by laypeople with little or no knowledge of the underlying objective data. A recommendation system is built upon this which can recommend products for consumption, including a user interface for receiving user input, which includes at least one of demographic data, desired level of psychoactivity, or prior experience with the product, a merchant interface for receiving merchant input, including at least one of general data descriptive of the regulated product, lab data descriptive of the regulated products chemical composition, and user data descriptive of subjective effects of the regulated product on a user; and a decision engine making a recommendation of product according to correlation of the lab data with the user data.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: April 30, 2024
    Assignee: Leafly Holdings, Inc.
    Inventors: Nickolas Jikomes, Marc Brandon Hensley, Jason Makuch, Andrew MacRae, Nathan Lauer, Matthew Bollen, Stephanie Smith, Camille Lim, Michael Wityk, Adam Hilborn, Sam Starr, Christian Ramsey, Renata Le Duartes, III, Santiago Seira, Anna Zeng
  • Publication number: 20040105778
    Abstract: The present invention relates to methods for terminal sterilization of solid forms of nanoparticulate active agent compositions via gamma irradiation. The nanoparticulate active agent has an effective average particle size of less than about 2 microns, prior to incorporation into a solid form for sterilization. The resultant sterilized compositions exhibit excellent redispersibility, homogeneity, and uniformity. Also encompassed are compositions made via the described method and methods of treating animals and humans using such compositions.
    Type: Application
    Filed: September 4, 2003
    Publication date: June 3, 2004
    Applicant: Elan Pharma International Limited
    Inventors: Robert Lee, Matthew Hilborn, Laura Kline, Janine Keller